First National Trust’s AstraZeneca AZN Stock Holding History

First National Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-2,719	Closed	-$202K	–	246
2014 Q2	$202K	Sell	2,719 -1,435	-35%	-$104K	0.04%	236
2014 Q1	$270K	Sell	4,154 -215	-5%	-$13.9K	0.05%	218
2013 Q4	$260K	Buy	+4,369	New	+$237K	0.05%	221

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

First National Trust's AZN Position: Q3 2014 in Review

First National Trust sold out of AstraZeneca (AZN) in Q3 2014, closing a stake of 2,719 shares — an estimated $202K sold.

First National Trust first reported a position in AZN in Q4 2013 and held it in 3 quarters. The position peaked at $270K in Q1 2014. 402 funds tracked by Wall St. Rank hold AZN as of Q3 2014.

First National Trust reported no remaining AstraZeneca position as of Q3 2014 after selling out during the quarter.
First National Trust sold 2,719 AstraZeneca shares in Q3 2014, an estimated $202K.
First National Trust first reported a position in AstraZeneca in Q4 2013 and held it in 3 quarters.
First National Trust's AstraZeneca position peaked at $270K in Q1 2014.
402 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2014.

Based on First National Trust's 13F filing for Q3 2014, filed 6 Nov 2014.